Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$4.83 - $7.35 $130,893 - $199,185
-27,100 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$6.16 - $12.07 $118,888 - $232,951
-19,300 Reduced 41.59%
27,100 $189,000
Q3 2021

Nov 16, 2021

SELL
$9.7 - $14.34 $247,349 - $365,670
-25,500 Reduced 35.47%
46,400 $464,000
Q2 2021

Aug 16, 2021

BUY
$13.43 - $19.16 $965,617 - $1.38 Million
71,900 New
71,900 $1.02 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.